|
1
|
Gentilin E, Tagliati F, Filieri C, Molè D,
Minoia M, Ambrosio M Rosaria, Uberti EC Degli and Zatelli MC:
miR-26a plays an important role in cell cycle regulation in
ACTH-secreting pituitary adenomas by modulating protein kinase Cδ.
Endocrinology. 154:1690–1700. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
D'Angelo D, Palmieri D, Mussnich P, Roche
M, Wierinckx A, Raverot G, Fedele M, Croce CM, Trouillas J and
Fusco A: Altered microRNA expression profile in human pituitary GH
adenomas: Down-regulation of miRNA targeting HMGA1, HMGA2 and E2F1.
J Clin Endocrinol Metab. 97:E1128–E1138. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yin Z, Williams-Simons L, Parlow AF, Asa S
and Kirschner LS: Pituitary-specific knockout of the Carney complex
gene Prkar1a leads to pituitary tumorigenesis. Mol Endocrinol.
22:380–387. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Özsu E, Mutlu GY, Çizmecioğlu FM and Hatun
Ş: McCune Albright syndrome in association with excessive GH
secretion: Case report. Turk Pediatri Ars. 50:114–117. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lania A and Spada A: G-protein and
signalling in pituitary tumours. Horm Res. 71 Suppl 2:S95–S100.
2009.
|
|
6
|
Jiang X and Zhang X: The molecular
pathogenesis of pituitary adenomas: An update. Endocrinol Metab
(Seoul). 28:245–254. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li XH, Wang EL, Zhou HM, Yoshimoto K and
Qian ZR: MicroRNAs in human pituitary adenomas. Int J Endocrinol.
2014:4351712014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Calin GA, Sevignani C, Dumitru CD, Hyslop
T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M
and Croce CM: Human microRNA genes are frequently located at
fragile sites and genomic regions involved in cancers. Proc Natl
Acad Sci USA. 101:pp. 2999–3004. 2004; View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stilling G, Sun Z, Zhang S, Jin L, Righi
A, Kovācs G, Korbonits M, Scheithauer BW, Kovacs K and Lloyd RV:
MicroRNA expression in ACTH-producing pituitary tumors:
up-regulation of microRNA-122 and −493 in pituitary carcinomas.
Endocrine. 38:67–75. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Butz H, Likó I, Czirják S, Igaz P,
Korbonits M, Rácz K and Patócs A: MicroRNA profile indicates
downregulation of the TGFβ pathway in sporadic non-functioning
pituitary adenomas. Pituitary. 14:112–124. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qian ZR, Asa SL, Siomi H, Siomi MC,
Yoshimoto K, Yamada S, Wang EL, Rahman MM, Inoue H, Itakura M, et
al: Overexpression of HMGA2 relates to reduction of the let-7 and
its relationship to clinicopathological features in pituitary
adenomas. Mod Pathol. 22:431–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mao ZG, He DS, Zhou J, Yao B, Xiao WW,
Chen CH, Zhu YH and Wang HJ: Differential expression of microRNAs
in GH-secreting pituitary adenomas. Diagn Pathol. 5:792010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bottoni A, Zatelli MC, Ferracin M,
Tagliati F, Piccin D, Vignali C, Calin GA, Negrini M, Croce CM and
Uberti EC Degli: Identification of differentially expressed
microRNAs by microarray: A possible role for microRNA genes in
pituitary adenomas. J Cell Physiol. 210:370–377. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Altuvia Y, Landgraf P, Lithwick G, Elefant
N, Pfeffer S, Aravin A, Brownstein MJ, Tuschl T and Margalit H:
Clustering and conservation patterns of human microRNAs. Nucleic
Acids Res. 33:2697–2706. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Korpal M, Lee ES, Hu G and Kang Y: The
miR-200 family inhibits epithelial-mesenchymal transition and
cancer cell migration by direct targeting of E-cadherin
transcriptional repressors ZEB1 and ZEB2. J Biol Chem.
283:14910–14914. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Burk U, Schubert J, Wellner U, Schmalhofer
O, Vincan E, Spaderna S and Brabletz T: A reciprocal repression
between ZEB1 and members of the miR-200 family promotes EMT and
invasion in cancer cells. EMBO Rep. 9:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Leskela S, Leandro-García LJ, Mendiola M,
Barriuso J, Inglada-Pérez L, Muñoz I, Martínez-Delgado B, Redondo
A, de Santiago J, Robledo M, et al: The miR-200 family controls
beta-tubulin III expression and is associated with paclitaxel-based
treatment response and progression-free survival in ovarian cancer
patients. Endocr Relat Cancer. 18:85–95. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia W, Li J, Chen L, Huang B, Li S, Yang
G, Ding H, Wang F, Liu N, Zhao Q, et al: MicroRNA-200b regulates
cyclin D1 expression and promotes S-phase entry by targeting RND3
in HeLa cells. Mol Cell Biochem. 344:261–266. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Basu A and Sivaprasad U: Protein kinase
Cepsilon makes the life and death decision. Cell Signal.
19:1633–1642. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Petiti JP, Gutiérrez S, De Paul AL,
Andreoli VCM, Ldel V Sosa, Bocco JL and Torres AI: GH3B6 pituitary
tumor cell proliferation is mediated by PKCalpha and PKCepsilon via
ERK 1/2-dependent pathway. Cell Physiol Biochem. 26:135–146. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hardy J and Vezina JL: Transsphenoidal
neurosurgery of intracranial neoplasm. Adv Neurol. 15:261–273.
1976.PubMed/NCBI
|
|
22
|
Knosp E, Steiner E, Kitz K and Matula C:
Pituitary adenomas with invasion of the cavernous sinus space: A
magnetic resonance imaging classification compared with surgical
findings. Neurosurgery. 33:610–618. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhao A, Zeng Q, Xie X, Zhou J, Yue W, Li Y
and Pei X: MicroRNA-125b induces cancer cell apoptosis through
suppression of Bcl-2 expression. J Genet Genomics. 39:29–35. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hu X, Xin Y, Xiao Y and Zhao J:
Overexpression of YAP1 is correlated with progression, metastasis
and poor prognosis in patients with gastric carcinoma. Pathol Oncol
Res. 20:805–811. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Fabian MR, Sonenberg N and Filipowicz W:
Regulation of mRNA translation and stability by microRNAs. Annu Rev
Biochem. 79:351–379. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
McManus MT: MicroRNAs and cancer. Semin
Cancer Biol. 13:253–258. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Muralidhar GG and Barbolina MV: The
miR-200 Family: Versatile players in epithelial ovarian cancer. Int
J Mol Sci. 16:16833–16847. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chang L, Guo F, Huo B, Lv Y, Wang Y and
Liu W: Expression and clinical significance of the microRNA-200
family in gastric cancer. Oncol Lett. 9:2317–2324. 2015.PubMed/NCBI
|
|
32
|
Bracken CP, Khew-Goodall Y and Goodall GJ:
Network-Based Approaches to Understand the Roles of miR-200 and
Other microRNAs in Cancer. Cancer Res. 75:2594–2599. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu W, Qi L, Lv H, Zu X, Chen M, Wang J,
Liu L, Zeng F and Li Y: MiRNA-141 and miRNA-200b are closely
related to invasive ability and considered as decision-making
biomarkers for the extent of PLND during cystectomy. BMC Cancer.
15:922015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kurashige J, Kamohara H, Watanabe M,
Hiyoshi Y, Iwatsuki M, Tanaka Y, Kinoshita K, Saito S, Baba Y and
Baba H: MicroRNA-200b regulates cell proliferation, invasion, and
migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg
Oncol. 19 Suppl 3:S656–S664. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yue CH, Huang CY, Tsai JH, Hsu CW, Hsieh
YH, Lin H and Liu JY: MZF-1/Elk-1 Complex Binds to Protein Kinase
Cα Promoter and Is Involved in Hepatocellular Carcinoma. PLoS One.
10:e01274202015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chen H, Yu Y, Rong S and Wang H:
Evaluation of diagnostic accuracy of DNA methylation biomarkers for
bladder cancer: A systematic review and meta-analysis. Biomarkers.
19:189–197. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hsu YH, Yao J, Chan LC, Wu TJ, Hsu JL,
Fang YF, Wei Y, Wu Y, Huang WC, Liu CL, et al: Definition of PKC-α,
CDK6, and MET as therapeutic targets in triple-negative breast
cancer. Cancer Res. 74:4822–4835. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Humphries B, Wang Z, Oom AL, Fisher T, Tan
D, Cui Y, Jiang Y and Yang C: MicroRNA-200b targets protein kinase
Cα and suppresses triple-negative breast cancer metastasis.
Carcinogenesis. 35:2254–2263. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sliva D, English D, Lyons D and Lloyd FP
Jr: Protein kinase C induces motility of breast cancers by
upregulating secretion of urokinase-type plasminogen activator
through activation of AP-1 and NF-kappaB. Biochem Biophys Res
Commun. 290:552–557. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tam WL, Lu H, Buikhuisen J, Soh BS, Lim E,
Reinhardt F, Wu ZJ, Krall JA, Bierie B, Guo W, et al: Protein
kinase C α is a central signaling node and therapeutic target for
breast cancer stem cells. Cancer Cell. 24:347–364. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Konopatskaya O and Poole AW: Protein
kinase Calpha: Disease regulator and therapeutic target. Trends
Pharmacol Sci. 31:8–14. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Urtreger AJ, Kazanietz MG and Bal de Kier
Joffé ED: Contribution of individual PKC isoforms to breast cancer
progression. IUBMB Life. 64:18–26. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Vrba L, Garbe JC, Stampfer MR and Futscher
BW: Epigenetic regulation of normal human mammary cell
type-specific miRNAs. Genome Res. 21:2026–2037. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Jadhav SP, Kamath SP, Choolani M, Lu J and
Dheen ST: microRNA-200b modulates microglia-mediated
neuroinflammation via the cJun/MAPK pathway. J Neurochem.
130:388–401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tong J, Fu Y, Xu X, Fan S, Sun H, Liang Y,
Xu K, Yuan Z and Ge Y: TGF-β1 stimulates human Tenon's capsule
fibroblast proliferation by miR-200b and its targeting of p27/kip1
and RND3. Invest Ophthalmol Vis Sci. 55:2747–2756. 2014. View Article : Google Scholar : PubMed/NCBI
|
